Literature DB >> 7629382

Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers.

J A Fagin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629382     DOI： 10.1007/BF03349723

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  11 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Identification of deletion mutations and three new genes at the familial polyposis locus.

Authors:  G Joslyn; M Carlson; A Thliveris; H Albertsen; L Gelbert; W Samowitz; J Groden; J Stevens; L Spirio; M Robertson
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

3.  Adenomatous polyposis: an association with carcinoma of the thyroid.

Authors:  R O Plail; H J Bussey; G Glazer; J P Thomson
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

4.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice.

Authors:  C Ledent; J Dumont; G Vassart; M Parmentier
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

5.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

8.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

Authors:  I Nishisho; Y Nakamura; Y Miyoshi; Y Miki; H Ando; A Horii; K Koyama; J Utsunomiya; S Baba; P Hedge
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

9.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

10.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728
View more
  8 in total

1.  A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Authors:  Janete M Cerutti; Rosana Delcelo; Marcelo João Amadei; Claudia Nakabashi; Rui M B Maciel; Bercedis Peterson; Jennifer Shoemaker; Gregory J Riggins
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.

Authors:  Xiaoyong Fan; Hongzhen Lu; Youqiang Cui; Xianzeng Hou; Chuanjiang Huang; Guangcun Liu
Journal:  Exp Ther Med       Date:  2018-03-08       Impact factor: 2.447

3.  Prognostic factors in differentiated thyroid cancer--a 20-year surgical outcome study.

Authors:  Aleksander Konturek; Marcin Barczyński; Wojciech Nowak; Piotr Richter
Journal:  Langenbecks Arch Surg       Date:  2012-02-15       Impact factor: 3.445

4.  Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas.

Authors:  Demet Corapcioglu; Serpil D Sak; Tuncay Delibasi; Vedia Tonyukuk; Nuri Kamel; Ali R Uysal; Savas Kocak; Semih Aydintug; Gurbuz Erdogan
Journal:  J Transl Med       Date:  2006-07-05       Impact factor: 5.531

5.  p53 regulates myogenesis by triggering the differentiation activity of pRb.

Authors:  A Porrello; M A Cerone; S Coen; A Gurtner; G Fontemaggi; L Cimino; G Piaggio; A Sacchi; S Soddu
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

6.  Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.

Authors:  Young Shin Song; Chan Kwon Jung; Kyeong Cheon Jung; Young Joo Park; Jae Kyung Won
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

7.  NVP-BEZ235 inhibits thyroid cancer growth by p53- dependent/independent p21 upregulation.

Authors:  Banjun Ruan; Wei Liu; Pu Chen; Rongrong Cui; Yu Li; Meiju Ji; Peng Hou; Qi Yang
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

8.  PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.

Authors:  Wei Liu; Fang Sui; Jiazhe Liu; Meichen Wang; Sijia Tian; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Oncotarget       Date:  2016-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.